Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • nr23
    Member
    • Oct 2012
    • 42

    #1

    Gene Ontology in non-model organisms

    I have a list of differentially expressed genes from an RNA-Seq experiment in Xenopus laevis that I'm looking to functionally annotate with GO-terms. As X.laevis is not listed in DAVID it seems I have 2 options:

    - BLAST my DE genes against a database with GO terms (human/mouse) to look for orthologs
    - Use a program that assigns GO from BLAST results, such as Blast2GO

    I've been trying with Blast2GO recently, but find if very slow and generally lacking - does anyone have any experience doing GO in Xenopus or other non-model organisms?
    Last edited by nr23; 02-12-2014, 01:51 PM.
  • Birdman
    Member
    • Jan 2014
    • 21

    #2
    I also tried Blast2Go without success using a non-model organism. After countless hours I gave up, since it was messing up my blast results IDs and at the end it was not even retrieving GO terms properly.

    Finally, I did the annotation with Trinotate and it went very smoothly. The steps are well described on the website. You need blast results as an input.

    Good luck with your analyses.

    Comment

    • amolkolte
      Junior Member
      • Dec 2012
      • 8

      #3
      InterProScan followed by BiNGO

      blast2go is on the verge of getting commercialized (as they have started selling PRO versions) and my previous experience was not so good with it. I used IntrProScan to associate GO terms with the transcript sequences. It was a long run but it also reported all the possible sequence features.

      To use these custom annotation was tricky for visualization, but thanks to BiNGO, I was able to do it flawlessly. For future use I have documented it here, http://infoplatter.blogspot.in/2014/...alysis-in.html

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 08-13-2026, 12:22 PM
      0 responses
      29 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-11-2026, 10:35 AM
      0 responses
      24 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-06-2026, 07:41 AM
      0 responses
      38 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-03-2026, 10:13 AM
      0 responses
      51 views
      0 reactions
      Last Post SEQadmin2  
      Working...